This brand name is authorized in Hong Kong
The drug RINGL AP contains a combination of these active pharmaceutical ingredients (APIs):
1
Ethenzamide
UNII L929ZCK4BF - ETHENZAMIDE
|
|
2
Caffeine
UNII 3G6A5W338E - CAFFEINE
|
Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant. |
3
Hydrotalcite
UNII 17432CG1KU - HYDROTALCITE
|
Hydrotalcite is a layered double hydroxide of general formula Mg6Al2CO3(OH)16ยท4(H2O), whose name is derived from its resemblance with talc and its high water content. The carbonate anions that lie between the structural layers are weakly bound, so hydrotalcite has anion exchange capabilities. Hydrotalcite is also used as an antacid. |
4
Propyphenazone
UNII OED8FV75PY - PROPYPHENAZONE
|
Propyphenazone is a pyrazolone derivative with anti-inflammatory, analgesic and antipyretic activity. As it is structurally related to aminophenazone it has been associated with severe blood dyscrasias. However, it cannot be transformed into potentially carcinogenic nitrosamines and has therefore been widely used as a replacement drug for aminophenazone. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: HK | Department of Health Drug Office | Identifier(s): 46414 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.